# Middle Meningeal Artery Embolization for Chronic Subdural Hematomas (STORMM)

> **NCT06163547** · NA · RECRUITING · sponsor: **University Hospital, Geneva** · enrollment: 180 (estimated)

## Conditions studied

- Chronic Subdural Hematomas
- Cerebral Compression Due to Injury

## Interventions

- **RADIATION:** MMA embolization

## Key facts

- **NCT ID:** NCT06163547
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-18
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06163547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06163547, "Middle Meningeal Artery Embolization for Chronic Subdural Hematomas (STORMM)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06163547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*